Casdin Capital »

Verastem shares owned by Casdin Capital

Quarter-by-quarter ownership of Verastem (VSTM) shares owned by Casdin Capital from 13F filings

Historical chart of Casdin Capital investment in Verastem

Tip: Access up to 7 years of quarterly data

All positions including Verastem held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verastem by Casdin Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $3.6M 600k 6.03

More positions owned by Casdin Capital

Genedx Holdings Corp Com Cl A (WGS)
Biolife Solutions Com New (BLFS)
Revolution Medicines (RVMD)
D Fluidigm Corp Del (LAB)
Avidity Biosciences Ord (RNA)
Relay Therapeutics (RLAY)
Illumina (ILMN)
Structure Therapeutics Sponsored Ads (GPCR)
Beam Therapeutics (BEAM)
Alnylam Pharmaceuticals (ALNY)
Tempus Ai Cl A (TEM)
Neurogene (NGNE)
Maze Therapeatics (MAZE)
Prime Medicine (PRME)
Silverback Therapeutics (SPRY)

View all positions for Casdin Capital

Top funds holding Verastem

Rtw Investments
Balyasny Asset Management
Logos Global Management
Point72 Asset Management
BlackRock
Vanguard Group
Stonepine Capital Management
Vivo Capital
Foresite Capital Management VI
State Street Corporation
Armistice Capital
Rosalind Advisors
Nantahala Capital Management
Geode Capital Management
Millennium Management

View all funds holding Verastem